Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403842 | 12540384 | 2 | F | 20160718 | 20160708 | 20160728 | PER | US-PFIZER INC-2016324345 | PFIZER | 75.00 | YR | F | Y | 75.00000 | KG | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403842 | 12540384 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | Oral | 250 MG, 2X/DAY, EVERY 12 HOURS | U | 20931 | 250 | MG | CAPSULE, HARD | BID | |||||
| 125403842 | 12540384 | 2 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 22.5 MG, WEEKLY, 2.5 MG AND EVERY MONDAY 7.5 MG | 0 | 22.5 | MG | TABLET | /wk | ||||||
| 125403842 | 12540384 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 125403842 | 12540384 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | QD | |||||||
| 125403842 | 12540384 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 125403842 | 12540384 | 6 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | QD | |||||||
| 125403842 | 12540384 | 7 | C | VIVELLE | ESTRADIOL | 1 | UNK | 0 | TRANSDERMAL PATCH | ||||||||||
| 125403842 | 12540384 | 8 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Oral | 50000 IU, 2X/WEEK | 0 | 50000 | IU | BIW | |||||||
| 125403842 | 12540384 | 9 | C | ASPIRIN BAYER | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125403842 | 12540384 | 1 | Cardiac ablation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125403842 | 12540384 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125403842 | 12540384 | Atrial fibrillation | |
| 125403842 | 12540384 | Blood thyroid stimulating hormone decreased | |
| 125403842 | 12540384 | Cardiac flutter | |
| 125403842 | 12540384 | Heart rate decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125403842 | 12540384 | 1 | 201602 | 0 |